WebFeb 28, 2024 · 2024 Outlook. Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 ... WebMay 11, 2024 · Presentation Operator MessageOperator Thank you for standing by, and welcome to the Cytek Biosciences First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, today's... April 12, 2024
Cytek Biosciences, Inc. (CTKB) Q4 Earnings Top Estimates - Yahoo
WebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … WebFeb 28, 2024 · Other than Cytek’s Northern Lights CLC system, which is available for clinical use in China and the European Union, Cytek’s products are for research use only – not for use in diagnostic procedures. Stock Information $8.75 NASDAQ GS: CTKB 0 … The Investor Relations website contains information about Cytek Biosciences's … Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Mar 24, 2024: 144: Filed by "insiders" prior intended sale of restricted stock. Non … Cytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call. … Cytek Biosciences, CEO. Wenbin Jiang, Ph.D. has served as Cytek’s Chief … The Investor Relations website contains information about Cytek Biosciences's … Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August … great clips martinsburg west virginia
行业研究报告哪里找-PDF版-三个皮匠报告
WebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? WebFeb 28, 2024 · Welcome to the Cytek Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] Please be... March 25, 2024. ... Analyst Recommendations on CYTEK BIOSCIENCES, INC. 03/07: Piper Sandler Adjusts Price Target on Cytek Biosciences to $15 From $18, Maintains Over.. MT. WebIn the wake of Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest US$70m market cap drop, institutional owners may be forced to take severe actions. Simply Wall St. Sep-07-22 01:27AM. RGAIA Investment: Cytek Biosciences (CTKB) is Profitable Today & Will be Even More So in the Future. Insider Monkey +5.29%. great clips menomonie wi